WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil KumarCEO2026-09-171,279$69.57
$88.98kSell
Neil KumarCEO2026-09-178,721$69.01
$601.87kSell
Neil KumarCEO2026-08-19100$85.65
$8.57kSell
Neil KumarCEO2026-08-198,100$83.86
$679.26kSell
Neil KumarCEO2026-08-191,800$84.69
$152.44kSell
Neil KumarCEO2026-08-1817,279$82.21
$1.42MSell
Neil KumarCEO2026-08-1814,602$82.99
$1.21MSell
Neil KumarCEO2026-08-181,199$83.77
$100.44kSell
Neil KumarCEO2026-08-181,900$81.15
$154.18kSell
Neil KumarCEO2026-08-1636,237$79.86
$2.89MSell

1 of 20

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP18.88%36,900,661$2.55BInsider
Viking Global Performance LLC13.62%26,620,991$1.84BInsider
Viking Global Investors LP9.49%18,555,375$1.28BInsider
Kkr Genetic Disorder LP6.78%13,260,971$918.06MInsider
Neil Kumar6.08%11,882,965$822.66MInsider
Frank McCormick0.71%1,394,933$96.57MInsider
Charles J. Homcy0.47%919,876$63.68MInsider
Thomas Trimarchi0.17%336,529$23.30MInsider
Michael Thomas Henderson0.14%274,211$18.98MInsider
Ali J. 1. Satvat0.09%169,983$11.77MInsider

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO0.10%56.78%Net SellingNet Selling
HALO0.11%30.25%Net SellingNet Selling
SMMT0.01%99.99%Net Buying
CORT0.04%99.96%Net BuyingNet Selling
BMRN0.10%1.81%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 0.10% institutional shareholders, 56.78% Bridgebio Pharma insiders, and 43.12% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 18.88% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $2.42B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.